Efficacy and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma

Authors: Marta, Guilherme Nader, da Fonseca, Leonardo G., Braghiroli, Maria Ignez, Moura, Fernando, Hoff, Paulo M., Sabbaga, Jorge

Source: Clinics. January 2021 76

Subject Terms: Hepatocellular Carcinoma, Older Adults, Sorafenib, Safety, Efficacy

File Description: text/html

Access URL: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322021000100221

Prognostic Impact of Primary Tumor Sidedness in Stage III Colorectal Cancer: Real-World Evidence from a Brazilian Cohort

Authors: Protásio, Bruno Medonça, de Castria, Tiago Biachi, Natalino, Renato, Mangone, Flávia R., Saragiotto, Daniel Fernandes, Sabbaga, Jorge, Hoff, Paulo M., Chammas, Roger

Source: In Clinical Colorectal Cancer March 2024 23(1):73-84

Panitumumab versus cetuximab in combination with irinotecan in refractory metastatic colorectal cancer

Authors: Braghiroli, Maria Ignez Freitas Melro ^{a, b}, Filho, Daniel Santos Rocha Sobral ^{a, ⁎}, Fagundes, Juliana Goes Martins ^a, Mendoza, Elizabeth Zambrano ^a, Neffa, Maria Fernanda Batistuzzo Vicentini ^a, Campos, Karla Souza ^a, da Fonseca, Leonardo Gomes ^{a, b}, Bonadio, Renata Colombo ^{a, b}, Talans, Aley ^a, Braghiroli, Oddone Freitas Melro ^{a, b}, Mathias-Machado, Maria Cecília ^a, Sabbaga, Jorge ^{a, b}, Moniz, Camila Motta Venchiarutti ^{a, b}, Hoff, Paulo Marcelo Gehm ^{a, b}

Source: In Cancer Treatment and Research Communications 2024 42

Epidemiology and Outcomes of Patients With Brain Metastases From Colorectal Cancer—Who Are These Patients?

Authors: Bonadio, Renata Colombo, Freitas, Guilherme Fialho, Batista, Daniel Negrini, Moreira, Otavio Augusto Noschang, Dias, Carla A.R., Castria, Tiago Biachi, Sabbaga, Jorge, Hoff, Paulo M.

Source: In Clinical Colorectal Cancer September 2021 20(3):e195-e200

Real-world Data for High-risk Stage II Colorectal Cancer – The Role of Tumor Side in the Adjuvant Setting

Authors: Araujo, Camila S., Venchiarutti Moniz, Camila M., Bonadio, Renata C., Watarai, Gabriel Y., Rojas, Jéssica, Nogueira, Pedro V.S., Martinez, Jéssica K., Moraes, Priscila M.G., Braghiroli, Maria I., Sabbaga, Jorge, Hoff, Paulo M.

Source: In Clinical Colorectal Cancer June 2021 20(2):e100-e108

Malignant bowel obstruction: effectiveness and safety of systemic chemotherapy.

Authors: Caparica, Rafael, Amorim, Larissa, Amaral, Paulo, Uratani, Lucas, Muniz, David, Hendlisz, Alain, de Azambuja, Evandro, Glasberg, João, Kenji Takahashi, Tiago, Filho, Elias Abdo, Canellas, Rodrigo, Saragiotto, Daniel, Sabbaga, Jorge, Mak, Milena

Source: BMJ Supportive & Palliative Care; Nov2024, Vol. 14 Issue e2, pe1882-e1888, 7p

Predictive biomarkers in colorectal adenocarcinoma – a Brazilian perspective on current and future practices.

Authors: Campos, Antonio Hugo José Fróes Marques, Auresco, Luciana Campi, Marins, Lidiane Vieira, Divino, Paulo Henrique do Amor, Sabbaga, Jorge, Hoff, Paulo Marcelo

Source: Surgical & Experimental Pathology; 10/8/2024, Vol. 7 Issue 1, p1-13, 13p

Safety and Efficacy of a Modified FLOX Adjuvant Regimen for Patients With Stage III Colorectal Cancer Treated in the Community

Authors: Protásio, Bruno Mendonça, Matutino, Adriana, Lage, Liana Valente, Santana, Iuri, Ramos, Ricardo, Sabbaga, Jorge, Capareli, Fernanda, Saragiotto, Daniel, Riechelmann, Rachel, Hoff, Paulo M.

Source: In Clinical Colorectal Cancer March 2017 16(1):65-72

Phase 2 Trial of Metformin Combined With 5-Fluorouracil in Patients With Refractory Metastatic Colorectal Cancer

Authors: Miranda, Vanessa C., Braghiroli, Maria Ignez, Faria, Luiza Dib, Bariani, Giovanni, Alex, Alexandra, Bezerra Neto, João Evangelista, Capareli, Fernanda C., Sabbaga, Jorge, Lobo dos Santos, Juliana Ferreira, Hoff, Paulo M., Riechelmann, Rachel P.

Source: In Clinical Colorectal Cancer December 2016 15(4):321-328

Prognostic Impact of Primary Tumor blaedness in Stage III Colorectal Cancer: Real-World Evidence from a Brazilian Cohort.

Authors: Protásio, Bruno Medonça, de Castria, Tiago Biachi, Natalino, Renato, Mangone, Flávia R., Saragiotto, Daniel Fernandes, Sabbaga, Jorge, Hoff, Paulo M., Chammas, Roger

Source: Clinical Colorectal Cancer; Mar2024, Vol. 23 Issue 1, p73-84, 12p

A phase II trial with anti-Lewis-Y monoclonal antibody (hu3S193) for the treatment of platinum resistant/refractory ovarian, fallopian tube and primary peritoneal carcinoma

Authors: Smaletz, Oren, Diz, Maria D.P.E., do Carmo, Claudio C., Sabbaga, Jorge, Cunha-Junior, Geraldo F., Azevedo, Sergio J., Maluf, Fernando C., Barrios, Carlos H., Costa, Ronaldo L., Fontana, Ana G., Madrigal, Vivian, Wainstein, Alberto J., Yeda, Fernanda P., Alves, Venâncio A., Moro, Ana M., Blasbalg, Roberto, Scott, Andrew M., Hoffman, Eric W.

Source: In Gynecologic Oncology August 2015 138(2):272-277

The Effects of Palliative Chemotherapy in Metastatic Colorectal Cancer Patients With an ECOG Performance Status of 3 and 4

Authors: Crosara Teixeira, Marcela, Marques, Daniel Fernandes, Ferrari, Anezka Celis, Alves, Michel Fabiano Silva, Alex, Alexandra Khichfy, Sabbaga, Jorge, Hoff, Paulo M., Riechelmann, Rachel P.

Source: In Clinical Colorectal Cancer March 2015 14(1):52-57

Suspected Germline TP53 Variants and Clonal Hematopoiesis of Indeterminate Potential: Lessons Learned From a Molecular Tumor Board.

Authors: Xavier, Camila B, Link, Rudinei, Abreu, Leonília, Bettoni, Fabiana, Marson, Fabiane, Galante, Pedro A F, Masotti, Cibele, Amano, Mariane T, Molla, Vinicius de, Camargo, Anamaria A, Asprino, Paula F, Sabbaga, Jorge

Source: Oncologist; Jul2023, Vol. 28 Issue 7, p624-627, 4p, 1 Chart, 2 Graphs

Subject Terms: BLOOD testing, TUMOR risk factors, TUMOR diagnosis, SALIVA analysis, GENETIC mutation, COMMITTEES, GENETICS, SEQUENCE analysis, DNA, GERM cells, ALLELES, LI-Fraumeni syndrome, MOLECULAR biology, RISK assessment, HEMATOPOIESIS, TUMORS, BONE marrow examination

A multi-centre randomized controlled trial investigating Consolidation Chemotherapy with and without oxaliplatin in distal rectal cancer and Watch & Wait.

Authors: Habr-Gama, Angelita, São Julião, Guilherme Pagin, Ortega, Cinthia D., Vailati, Bruna Borba, Araujo, Sergio, Jorge, Thiago, Sabbaga, Jorge, Rossi, Gustavo L., D'Alpino, Renata, Kater, Fabio Roberto, Aguilar, Patricia Bailão, Mattacheo, Adrian, Perez, Rodrigo Oliva

Source: BMC Cancer; 6/14/2023, Vol. 23 Issue 1, p1-10, 10p

Subject Terms: CONSOLIDATION chemotherapy, RECTAL cancer, RANDOMIZED controlled trials, OXALIPLATIN, RECTUM tumors, COLOSTOMY, FERTILITY preservation

Low‐energy amplitude‐modulated electromagnetic field exposure: Feasibility study in patients with hepatocellular carcinoma.

Authors: Capareli, Fernanda, Costa, Frederico, Tuszynski, Jack A., Sousa, Micelange C., Setogute, Yone de C., Lima, Pablo D., Carvalho, Luciana, Santos, Elizabeth, Gumz, Brenda P., Sabbaga, Jorge, de Castria, Tiago B., Jardim, Denis L., Freitas, Daniela, Horvat, Natally, Bezerra, Regis O. F., Testagrossa, Leonardo, Costa, Tiago, Zanesco, Tatiana, Iemma, Antonio F., Abou‐Alfa, Ghassan K.

Source: Cancer Medicine; Jun2023, Vol. 12 Issue 11, p12402-12412, 11p

Subject Terms: ELECTROMAGNETIC fields, FEASIBILITY studies, QUALITY of life

Monoallelic deleterious MUTYH germline variants as a driver for tumorigenesis.

Authors: Barreiro, Rodrigo Araujo Sequeira, Sabbaga, Jorge, Rossi, Benedito M, Achatz, Maria Isabel W, Bettoni, Fabiana, Camargo, Anamaria A, Asprino, Paula F, A F Galante, Pedro

Source: Journal of Pathology; Feb2022, Vol. 256 Issue 2, p214-222, 9p

Subject Terms: GERM cells, DNA repair, NEOPLASTIC cell transformation, DISEASE risk factors, HETEROZYGOSITY

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.